Miaomiao Li

Effect of infection with hepatitis B virus on the survival outcome of diffuse large B-cell lymphoma in the prophylactic antiviral era

Jun Zhu, Hong Zhao, Weiping Liu, 2022, Frontiers in Oncology.

Clinical implications of circulating tumor DNA in predicting the outcome of diffuse large B cell lymphoma patients receiving first-line therapy

Jun Zhu, Hui Yu, L. Mi, 2022, BMC Medicine.

Survival and prognostic analysis of T-cell lymphoblastic lymphoma patients treated with dose-adjusted BFM-90 regimen

Jun Zhu, Hui Yu, L. Mi, 2022, Aging.

Anti‐CD47 immunotherapy in combination with BCL‐2 inhibitor to enhance anti‐tumor activity in B‐cell lymphoma

Shaokun Shu, Jun Zhu, Hui Yu, 2022, Hematological oncology.

Ibrutinib combined with low‐dose histone deacetylases inhibitor chidamide synergistically enhances the anti‐tumor effect in B‐cell lymphoma

Jun Zhu, Hui Yu, L. Mi, 2022 .

HSF1 is involved in immunotherapeutic response through regulating APOJ/STAT3-mediated PD-L1 expression in hepatocellular carcinoma

K. Guo, Jing Ma, Dongmei Gao, 2022, Cancer biology & therapy.

Ibrutinib combined with low‐dose histone deacetylases inhibitor chidamide synergistically enhances the anti‐tumor effect in B‐cell lymphoma

Jun Zhu, Hui Yu, L. Mi, 2022, Hematological oncology.